Emtricitabine, Rilpivirine, Tenofovir Drug Combination

Known as: Combination, Emtricitabine-Rilpivirine-Tenofovir Drug, Emtricitabine, Rilpivirine, Tenofovir Drug Combination [Chemical/Ingredient], Drug Combination, Emtricitabine-Rilpivirine-Tenofovir 
A pharmaceutical preparation that contains emtricitabine, rilpivirine and tenofovir disoproxil fumarate. It is used to treat HIV INFECTIONS.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Objectives To analyse lipid changes and tolerability in a cohort of HIV-infected patients who switched their antiretroviral… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2017
Review
2017
BACKGROUND Few data are available about efficacy and durability of simplification from multi-tablet antiretroviral regimens to co… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2017
2017
It is estimated that up to 14% of patients with HIV have diabetes mellitus (DM), which is a determinant risk factor for the… (More)
Is this relevant?
2016
2016
Background.  Many human immunodeficiency virus (HIV)-infected patients remain on nevirapine-based antiretroviral therapy (ART… (More)
  • figure 1
  • table 2
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2015
2015
BACKGROUND Completion rates for human immunodeficiency virus (HIV) postexposure prophylaxis (PEP) are low. We investigated the… (More)
  • figure 1
  • figure 2
Is this relevant?
2014
2014
INTRODUCTION Emtricitabine/rilpivirine/tenofovir (EVP) is a fixed-dose combination of antiretrovirals (ARV) approved by the… (More)
  • table 1
Is this relevant?
Review
2013
Review
2013
A recent addition to the anti-human immunodeficiency virus armamentarium of drugs is rilpivirine, which is a potent non… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
BACKGROUND Antiretroviral preexposure prophylaxis is a promising approach for preventing human immunodeficiency virus type 1 (HIV… (More)
Is this relevant?
2012
2012
Fixed-dose combination tablets have become an important therapy option for patients infected with the human immunodeficiency… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
Purpose of the study : Rilpivirine (RPV) is a new non-nucleoside reverse transcriptase inhibitor (NNRTI) which has shown non… (More)
Is this relevant?